Form 4: Chemours Co Director Livingston Satterthwaite Reports Acquisition of Stock Units
SEC Form 4 Filing
Director Livingston Satterthwaite reports acquiring 14,096 stock units of Chemours Co, convertible to common stock upon separation from service.
Summary
- Livingston Satterthwaite, a director of Chemours Co, filed a Form 4 on April 24, 2025, reporting a transaction on April 22, 2025.
- Satterthwaite acquired 14,096 shares of common stock units.
- These stock units will convert one-for-one to Chemours common stock upon separation from service on the board.
- Following the transaction, Satterthwaite beneficially owns 23,029.9816 shares, including stock units and dividend equivalent units.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, reflecting a standard transaction. There is no indication of positive or negative sentiment.
Industry Context
This filing is a routine disclosure of a director's stock unit acquisition, which is common in executive compensation packages.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it involves stock units granted to a director as part of their compensation.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | Date of transaction: Acquisition of stock units. |
| 04/24/2025 | Date of Form 4 filing. |
Keywords
Form 4, Chemours Co, Director, Stock Units, Beneficial Ownership, Satterthwaite
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.